The S492R EGFR ectodomain mutation is never detected in KRAS wild-type colorectal carcinoma before exposure to EGFR monoclonal antibodies

The activity of the epidermal growth factor receptor (EGFR) antibodies cetuximab and panitumumab in metastatic colorectal carcinoma (mCRC) is significantly limited by molecular mechanisms leading to intrinsic or acquired resistance. The S492R mutation of the EGFR, which is caused by either the 1476C...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Esposito, Claudia, Rachiglio, Anna Maria, La Porta, Maria Libera, Sacco, Alessandra, Roma, Cristin, Iannaccone, Alessia, Tatangelo, Fabiana, Forgione, Laura, Pasquale, Raffaella, Barbaro, Americo, Botti, Gerardo, Ciardiello, Fortunato, Normanno, Nicola
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Landes Bioscience 2013
Pynciau:
Research Paper
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3912037/
https://ncbi.nlm.nih.gov/pubmed/24025416
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.26340
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg